Skip to main content

ORIGINAL RESEARCH article

Front. Public Health

Sec. Public Health Policy

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1562191

This article is part of the Research Topic Impact Evaluation using the Translational Science Benefits Model Framework in the National Center for Advancing Translational Science Clinical and Translational Science Award Program View all articles

Navigating the Road Ahead: Using Concept Mapping to Assess CTSA Program Goals

Provisionally accepted
Cathleen T. Kane Cathleen T. Kane 1*William Michael Trochim William Michael Trochim 2Haim Yehuda Barr Haim Yehuda Barr 3Andie Vaught Andie Vaught 4Heather L. Baker Heather L. Baker 4Munziba T. Khan Munziba T. Khan 4Robin Marian Wagner Robin Marian Wagner 4Keith Alan Herzog Keith Alan Herzog 5Kristi Holmes Kristi Holmes 5Jamie Mihoko Doyle Jamie Mihoko Doyle 4
  • 1 Institute of Clinical & Translational Science,School of Medicine, New York University, New York, United States
  • 2 Cornell Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, New York, United States
  • 3 Department of Statistics, College of Liberal Arts and Sciences, University of Connecticut, Storrs, Connecticut, United States
  • 4 National Center for Advancing Translational Sciences (NIH), Bethesda, Maryland, United States
  • 5 Northwestern University Feinberg School of Medicine, Northwestern University Clinical and Translational Sciences (NUCATS) Institute, Chicago, United States

The final, formatted version of the article will be published soon.

    Evaluating large-scale programs designed to transform public health demands innovative approaches for navigating their complexity and scope. The Clinical and Translational Science Awards (CTSA) Program, supported by the NIH's National Center for Advancing Translational Sciences (NCATS), represents a significant national investment with over 60 sites or "hubs" spread across the country. Assessing an initiative of this size and complexity requires measures that balance local flexibility with national coherence. To that end, this study used concept mapping, a mixed-methods approach integrating qualitative brainstorming and sorting with quantitative multidimensional scaling and cluster analysis. Participation across the CTSA was unprecedented. Over 100 evaluation stakeholders were engaged across the network of hubs, leading to the identification of more than 80 measures, which were then organized into thematic clusters that reflect a logical progression from CTSA activities to outcomes and impacts, as well as critical foundational factors such as collaboration and education. The results also revealed a pattern where long-term impacts were ranked among the highest in importance but among the lowest in feasibility, particularly for measures tied to the Translational Science Benefits Model (TSBM), a new evaluation framework gaining popularity across the CTSA. The findings of this study underscore the efficacy of concept mapping in incorporating wide-ranging perspectives, identifying areas of consensus, and informing leadership in the development of unified, data-driven evaluation frameworks -such as TSBM and/or a CTSA logic model-critical to maximizing the CTSA's transformative potential for public health.

    Keywords: Clinical and Translational Science Awards (CTSA), concept mapping, evaluation study, stakeholder participation, Mixed-methods Research, translational science benefits model (TSBM), Longitudinal impact, National institutes of health (NIH)

    Received: 17 Jan 2025; Accepted: 10 Mar 2025.

    Copyright: © 2025 Kane, Trochim, Barr, Vaught, Baker, Khan, Wagner, Herzog, Holmes and Doyle. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Cathleen T. Kane, Institute of Clinical & Translational Science,School of Medicine, New York University, New York, 10016, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more